Ranunculales Medicinal Plants
Biodiversity, Chemodiversity and Pharmacotherapy
Nonfiction, Health & Well Being, Medical, Medical Science, Pharmacology, Science & Nature, Science, Biological Sciences, Botany
| Author: | Da-Cheng Hao | ISBN: | 9780128142332 |
| Publisher: | Elsevier Science | Publication: | April 23, 2018 |
| Imprint: | Academic Press | Language: | English |
| Author: | Da-Cheng Hao |
| ISBN: | 9780128142332 |
| Publisher: | Elsevier Science |
| Publication: | April 23, 2018 |
| Imprint: | Academic Press |
| Language: | English |
Ranunculales Medicinal Plants: Biodiversity, Chemodiversity and Pharmacotherapy comprehensively covers this order of flowering plants, detailing the phytochemistry, chemotaxonomy, molecular biology, and phylogeny of selected medicinal plants families and genera and their relevance to drug efficacy. The book carries out an exhaustive survey of the literature in order to characterize global trends in the application of flexible technologies. The interrelationship between Chinese species, and between Chinese and non-Chinese species, is inferred through molecular phylogeny and based on nuclear and chloroplast DNA sequencing. The book discusses the conflict between chemotaxonomy and molecular phylogeny in the context of drug discovery and development.
Users will find invaluable and holistic coverage on the study of Ranunculales that will make this the go-to pharmaceutical resource.
- Describes current perceptions of biodiversity and chemodiversity of Ranunculales
- Explains how the conceptual framework of plant pharmacophylogeny benefits the sustainable exploitation of Ranunculales
- Details how Ranunculales medicinal plants work from the chemical level upward
- Covers how the polypharmacology of Ranunculales compounds might inspire new chemical entity design and development for improved treatment outcomes
Ranunculales Medicinal Plants: Biodiversity, Chemodiversity and Pharmacotherapy comprehensively covers this order of flowering plants, detailing the phytochemistry, chemotaxonomy, molecular biology, and phylogeny of selected medicinal plants families and genera and their relevance to drug efficacy. The book carries out an exhaustive survey of the literature in order to characterize global trends in the application of flexible technologies. The interrelationship between Chinese species, and between Chinese and non-Chinese species, is inferred through molecular phylogeny and based on nuclear and chloroplast DNA sequencing. The book discusses the conflict between chemotaxonomy and molecular phylogeny in the context of drug discovery and development.
Users will find invaluable and holistic coverage on the study of Ranunculales that will make this the go-to pharmaceutical resource.
- Describes current perceptions of biodiversity and chemodiversity of Ranunculales
- Explains how the conceptual framework of plant pharmacophylogeny benefits the sustainable exploitation of Ranunculales
- Details how Ranunculales medicinal plants work from the chemical level upward
- Covers how the polypharmacology of Ranunculales compounds might inspire new chemical entity design and development for improved treatment outcomes
